DIABETIC END STAGE RENAL DISEASE

This adverse event was reported 52 times

These drugs are most commonly taken by patients reporting DIABETIC END STAGE RENAL DISEASE:

# Drug Count
0 LANSOPRAZOLE 19
1 OMEPRAZOLE MAGNESIUM 15
2 ESOMEPRAZOLE MAGNESIUM 14
3 OMEPRAZOLE 12
4 PANTOPRAZOLE 10
5 ESOMEPRAZOLE 8
6 AMLODIPINE BESYLATE 5
7 ATORVASTATIN CALCIUM 5
8 ASPIRIN 4
9 ASPIRIN 325 MG 4
See all common drugs associated with DIABETIC END STAGE RENAL DISEASE

DIABETIC END STAGE RENAL DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OMEPRAZOLE AND SODIUM BICARBONATE 2 0.0007
1 CEFADROXIL 1 0.0005
2 CALCITONIN SALMON 1 0.0003
3 HUMAN INSULIN 1 0.0001
4 LANSOPRAZOLE 19 0.0001
5 ACETYLCYSTEINE 1 0.0001
6 EPOETIN ALFA 1 0.0001
7 INSULIN HUMAN 3 0.0001
8 DEXLANSOPRAZOLE 3 0.0001
9 ESOMEPRAZOLE MAGNESIUM 14 0.0001
See all drugs enriched for association with DIABETIC END STAGE RENAL DISEASE

DIABETIC END STAGE RENAL DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Insulin [EPC] 4 0.0001
2 Non-narcotic Antitussive [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Proton Pump Inhibitor [EPC] 19 0.0000
5 Cardiac Glycoside [EPC] 2 0.0000
6 Muscle Relaxant [EPC] 1 0.0000
7 Macrolide Antimicrobial [EPC] 1 0.0000
8 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
See all drug classes enriched for association with DIABETIC END STAGE RENAL DISEASE